Medical School: Vanderbilt University School of Medicine, Nashville, TN
Residency: Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
Fellowship: Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
Master of Health Science: Clinical Investigation, Johns Hopkins University School of Medicine, Baltimore, MD
American Board of Internal Medicine – Pulmonary Disease
American Board of Internal Medicine – Critical Care Medicine
American Board of Internal Medicine – Internal Medicine
Seleziona premi, risultati e pubblicazioni
Eberlein M, Arnaoutakis GJ, Yarmus L, Feller-Kopman D, Dezube R, et al: The effect of lung size mismatch on complications and resource utilization after bilateral lung transplantation. J Heart Lung Transplant 31(5):492-500, 2012.
Dezube R, Arnaoutakis GJ, Reed RM, et al: The effect of lung-size mismatch on mechanical ventilation tidal volumes after bilateral lung transplantation. Interact Cardiovasc Thorac Surg 16(3):275-281, 2013.
Desai SV, Feldman L, Brown L, Dezube R, et al: Effect of the 2011 vs 2003 duty hour regulation-compliant models on sleep duration, trainee education, and continuity of patient care among internal medicine house staff: a randomized trial. JAMA Intern Med
Jennings MT, Dezube R, Paranjape S, et al: An observational study of outcomes and tolerances in patients with cystic fibrosis initiated on lumacaftor/ivacaftor. Ann Am Thorac Soc 14(11):1662-1666, 2017.
Dezube R, Jennings MT, Rykiel M, et al: Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. J Cyst Fibros 18(3):357-363, 2019.
Akshintala VS, Kamal A, Faghih M, Cutting GR, Cebotaru L, West NE, Jennings MT, Dezube R, et al: Cystic fibrosis transmembrane conductance regulator modulators reduce the risk of recurrent acute pancreatitis among adult patients with pancreas sufficient
Safirstein J, Grant JJ, Clausen E, Savant D, Dezube R, Hong G. Biliary disease and cholecystectomy after initiation of elexacaftor/ivacaftor/tezacaftor in adults with cystic fibrosis. J Cyst Fibros S1569-1993(20)30806-7, 2020.
Montemayor K, Psoter KJ, Lechtzin N, Carson SW, Merlo CA, Dezube RH, et al: Sex differences in treatment patterns in cystic fibrosis pulmonary exacerbations. J Cyst Fibros S1569-1993(21)00163-6, 2021.